Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
42.58 USD | -1.81% | -4.86% | -17.10% |
05:12pm | Bristol Myers: national schizophrenia campaign | CF |
02:34pm | Bristol-Myers Squibb Says US FDA Reassigns Action Date Subcutaneous Nivolumab | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.10% | 87.9B | |
+38.23% | 705B | |
+32.82% | 583B | |
-3.63% | 364B | |
+20.16% | 332B | |
+5.11% | 291B | |
+16.64% | 238B | |
-4.13% | 210B | |
+10.63% | 209B | |
+8.80% | 169B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Transcript : Bristol-Myers Squibb Company, Q4 2023 Earnings Call, Feb 02, 2024